Mycoplasma hominis, Ureaplasma urealyticum and Chlamydia trachomatis Respiratory Colonization in Malaysian Preterm

Khuen Foong Ng1, Kah Kee Tan2, Mi-Chelle Chok2

  • 1Paediatric Infectious Diseases and Immunology, Great North Children's Hospital, NE1 4LP England; Department of Paediatrics, Tuanku Jaafar Hospital, 70300 Seremban, Malaysia.

Insights

Respiratory colonization by Mycoplasma hominis, Ureaplasma urealyticum, and Chlamydia trachomatis is uncommon in preterm infants. Judicious antibiotic use is recommended, as empirical treatment is often unnecessary for these infections.

Area of Science:

  • Neonatal Medicine
  • Microbiology
  • Pediatric Infectious Diseases

Background:

  • Respiratory infections are a concern in preterm infants.
  • Mycoplasma hominis (MH), Ureaplasma urealyticum (UU), and Chlamydia trachomatis (CT) can cause respiratory issues.
  • Data on the incidence of these specific pathogens in preterm infants is limited.

Purpose of the Study:

  • To determine the incidence of MH, UU, and CT respiratory colonization in preterm infants (<37 weeks gestation).
  • To identify predictors and clinical features associated with colonization.
  • To evaluate the effectiveness of empirical macrolide treatment.

Main Methods:

  • Prospective observational study of 200 preterm infants admitted for respiratory distress.
  • Respiratory secretions analyzed for MH, UU, and CT using polymerase chain reaction (PCR).
  • Association with preterm prelabor rupture of membranes (PPROM) analyzed.

Main Results:

  • Overall incidence of MH, UU, or CT colonization was 7.5% (15/200).
  • PPROM was a significant predictor (OR 3.7; 95% CI 1.2-11.3).
  • Only 4.1% of infants receiving empirical macrolides were positive for these organisms.

Conclusions:

  • The incidence of UU colonization is lower than reported elsewhere; MH and CT rates are comparable.
  • Empirical antibiotic use for suspected UU, MH, or CT infections in preterm infants should be judicious.
  • Further research into targeted antimicrobial therapy is warranted.